Reuters Health)- After the heavy criticisms of the new president Donald Trump, Big Pharma USA launches a media campaign to improve the public image of the sector. The heads of PhRMA, the association of US pharmaceutical industries, have announced that it will be a campaign in grand style.
However, PhRMA's campaign planning began six months ago, well before the presidential election in November, with the drafting of a regulatory and legislative agenda to be articulated in a robust lobbying campaign, with the FDA and insurance companies.
Source: Reuters Health News
(Italian version for Daily Health Industry)
26 gennaio, 2017 – Daily Health Industry
Related news: Trump, the opposite liberal to negotiate the price of US drugs